Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma

Clinical trial NCT00071981 · COMPLETED

Trial details

NCT number: NCT00071981
Sponsor: Eastern Cooperative Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2005-05-09
Primary completion: 2011-08-01
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.